| Description | RdRP-IN-3, a potential anti-influenza drug candidate, functions by inhibiting the activity of RNA-dependent RNA polymerase (RdRp). |
| molecular weight | 427.46 |
| Molecular formula | C25H21N3O4 |
| CAS | 2641299-75-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Tang L, et al. Synthesis and Anti-Influenza Virus Effects of Novel Substituted Polycyclic Pyridone Derivatives Modified from Baloxavir. J Med Chem. 2021 Oct 14;64(19):14465-14476. |